In last trading session, Intensity Therapeutics Inc (NASDAQ:INTS) saw 70854.0 shares changing hands with its beta currently measuring 5.06. Company’s recent per share price level of $1.98 trading at $0.11 or 6.05% at ring of the bell on the day assigns it a market valuation of $29.89M. That closing price of INTS’s stock is at a discount of -294.95% from its 52-week high price of $7.82 and is indicating a premium of 24.24% from its 52-week low price of $1.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 35090.0 shares which gives us an average trading volume of 27.85K if we extend that period to 3-months.
Intensity Therapeutics Inc (NASDAQ:INTS) trade information
Upright in the green during last session for gaining 6.05%, in the last five days INTS remained trading in the green while hitting it’s week-highest on Wednesday, 01/08/25 when the stock touched $1.98 price level, adding 6.6% to its value on the day. Intensity Therapeutics Inc’s shares saw a change of 12.49% in year-to-date performance and have moved 12.49% in past 5-day. Intensity Therapeutics Inc (NASDAQ:INTS) showed a performance of -28.01% in past 30-days. Number of shares sold short was 44277.0 shares which calculate 3.05 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 60.4% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -152.53% in reaching the projected high whereas dropping to the targeted low would mean a loss of -152.53% for stock’s current value.
Intensity Therapeutics Inc (INTS) estimates and forecasts
Statistics highlight that Intensity Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -59.60% of value to its shares in past 6 months, showing an annual growth rate of 14.49% while that of industry is 17.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -35.31% during past 5 years.
Intensity Therapeutics Inc (NASDAQ:INTS)’s Major holders
Insiders are in possession of 47.16% of company’s total shares while institution are holding 12.49 percent of that, with stock having share float percentage of 23.63%. Investors also watch the number of corporate investors in a company very closely, which is 12.49% institutions for Intensity Therapeutics Inc that are currently holding shares of the company.
